During the past decade, Georgia Regents Research Institute conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Georgia Regents Research Institute" are "Coronary Artery Disease" (1 trials), "Fecal Incontinence" (1 trials) and "Lymphoma" (1 trials). Many other conditions were trialed in "Georgia Regents Research Institute" in a lesser frequency.

Most popular intervention types in "Georgia Regents Research Institute" are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Percutaneous Coronary Intervention" (1 trials), "ibrutinib" (1 trials) and "itacitinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Georgia Regents Research Institute" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Georgia Regents Research Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Georgia Regents Research Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Georgia Regents Research Institute, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".